BDNF and Alzheimer disease: BDNF, which can be modulated under conditions of neuroinflammation, is reduced in the brains of individuals with AD, and a study by Kim et al. reported that cannabidiolic acid (CBDA), the precursor of CBD, increased hippocampal BDNF levels in Aβ-treated ICR mice [137].